The objective of this study was to investigate the predictors and prognostic significance of post-procedural cardiac troponin (cTn)-I elevations in a consecutive series of patients who underwent elective percutaneous coronary intervention (PCI). cTn-I was measured in 100 patients immediately before and within 24 h after the elective PCI. Post-procedural cTn-I elevation was observed in 27 of the 100 patients. In multivariate analysis, basal haemoglobin values and the number of repeated balloon dilatations were found to be independent predictors of cTn-I elevation. During the followup period of 12 ± 1.2 months, the cTn-I-positive group had more major adverse cardiovascular events than the cTn-I-negative group (33.3% versus 16.4%, respectively), but the difference was not significant. An increase in cTn-I levels following elective PCI procedures was frequent but did not predict a poor longterm outcome. A Izgi, AC Tanalp, C Kirma et al. Significance of troponin-I release after coronary angioplasty levels after successful PCI. This study investigated the effects of clinical, angiographic and procedural features on postprocedural cTn-I elevation and the relationship between cTn-I elevation and cardiovascular end-points during a followup of 1 year.
Introduction
Atherosclerotic coronary artery disease is one of the leading causes of mortality and morbidity. Percutaneous transluminal coronary angioplasty (PTCA) and intracoronary stent implantation have radically changed the management of coronary artery disease, although some complications remain unresolved. 1,2 With respect to these complications, the elevation of cardiacspecific biomarkers, such as creatine kinase (CK), CK-MB isoform and troponins, after percutaneous coronary intervention (PCI) has been reported previously. 3, 4 Peri-procedural ischaemia and necrosis due to prolonged balloon inflation, acute occlusion of a side branch, occlusive dissection or distal embolization may be responsible for this elevation. CK and CK-MB levels may also increase after uncomplicated PCI. 5 Compared with CK, CK-MB isoform and cardiac troponin (cTn)-T, cTn-I is a more sensitive biomarker of myocardial injury. 6 Despite large-scale prospective studies on the mechanisms and prognosis of postprocedural CK and CK-MB release, 7,8 there has been no consensus on the predictive factors and the outcomes of elevated cTn-I
BLOOD SAMPLING
Blood samples were withdrawn 1 h before PCI and re-samplings were obtained between 6 and 24 h after the procedure. In cases of multiple sampling during this period, the highest level was used as the index value for the final evaluation. The cTn-I levels were analysed quantitatively each day by the calibrated immunochemiluminometric method (Access ® 2 System; Beckman Coulter, Fullerton, California, USA). A cTn-I level above 0.08 ng/ml was considered significant for myocardial damage, and patients with such a value were labelled as cTn-I-positive (+). This level is the standard value suggested by the manufacturer.
CORONARY ANGIOGRAPHY AND PERCUTANEOUS CORONARY INTERVENTION
Coronary angiography and PCI were performed with standard techniques by invasive cardiologists who had had experience of 75 or more PCIs per year. The coronary angiography and PCI were performed via the femoral artery after 6 -8 h of fasting. Anticoagulant drugs were stopped 48 h before the angiography. All patients were medicated with 300 mg aspirin, orally, and a 300 mg loading dose of clopidogrel, orally, pre-procedurally. In all patients, clopidogrel 75 mg/day was continued for at least 2 months. At the beginning of each procedure, 10 000 U unfractioned heparin was administered from the femoral sheath. The use of the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban during the procedure was left to the physician's discretion. In patients to whom tirofiban was administered, the drug was used at a loading dose of 10 µg/kg, followed by infusion at the rate of 0.15 µg/kg per min for at least 24 h.
All angiographic measurements were made using a quantitative angiography system (Axiom Artis FC™ QCA system; Siemens, Forchheim, Germany). The coronary lesion classification system of the American College of Cardiology/American Heart Association (ACC/AHA) was used for the final classification of the lesions. 9 In patients with multiple intervened lesions, the final classification was made according to the lesion with the highest ACC/AHA level. Epicardial blood flow was evaluated by the Thrombolyis in Myocardial Infarction (TIMI) grading method. 10 Achievement of a residual stenosis of less than 30% after PTCA or less than 20% after stent implantation and distal TIMI grade 3 flow was defined as a procedural success. Significance of troponin-I release after coronary angioplasty
END-POINTS
The primary end-point of the study was postprocedural cTn-I positivity, and secondary end-points were major adverse cardiovascular events (MACE; cardiac death, AMI and recurrent PCI or coronary artery bypass surgery) during follow-up. If more than one end-point occurred in a patient during follow-up, the first end-point was used for the final analysis. In hospital, end-points were recorded from clinical visits and hospital records. During the follow-up at 1 month and 12 months, relevant data were collected from clinical visits, phone calls and archive records of the patients who were admitted with recurrent symptoms.
DEFINITIONS
Acute myocardial infarction was defined as the presence of (i) typical chest pain with a duration longer than 30 min; and (ii) ST-segment elevation greater than 1 mm in two consecutive leads or a new left bundle branch block with an elevation of CK and CK-MB isoform. Deaths among the study group from congestive heart failure, arrhythmias, AMI or sudden death (death within 1 h of cardiac symptoms) were defined as cardiac death.
STATISTICAL ANALYSIS
The data were expressed as mean ± SD. Continuous variables were compared using the unpaired Student's t-test and the Mann-Whitney U-test. Categorical variables were compared using the χ 2 test. Fisher's exact test was used when the expected value of at least one cell was less than 5. Multiple stepwise logistic regression analysis was used to determine independent predictors of cTn-I elevation. All significant univariate predictors from Tables 1 and 2 were included in the analysis. For the estimation of the relative risk of cTn-I elevation for in-hospital, 1-month and 1-year major adverse cardiovascular events, the odds ratio (OR) was calculated and the statistical significance was tested by χ 2 analysis. Receiver operating characteristic (ROC) curve analysis was performed to determine the cut-off value for the haemoglobin level to predict cTn-I elevation. Correlation analysis was performed with the Spearman test. SPSS ® for Windows version 10.0 (SPSS Inc., Chicago, Illinois, USA) was used for statistical analysis. P-values < 0.05 were considered to be statistically significant.
Results

CLINICAL AND DEMOGRAPHIC DATA
A total of 136 patients were enrolled in the study between January and April 2003. Thirty-six patients were excluded and the remaining 100 patients constituted the study group. The distribution of the clinical and demographic properties in patients with and without cTn-I elevation is shown in Table 1 . No statistically significant differences were observed between cTn-I(+) and (−) patients with regard to age, gender, total cholesterol levels, medications and previous myocardial infarctions. Comparing the clinical variables, only basal haemoglobin values of cTn-I(+) patients were significantly lower than those of cTn-I(−) patients (13.2 ± 1.9 g/dl versus 14.7 ± 1.5 g/dl, respectively, P < 0.001).
ANGIOGRAPHIC AND PROCEDURAL PROPERTIES
A comparison of the angiographic and procedural features is shown in Table 2 . There were no significant differences between the two groups with regard to the type of intervention, lesion types and pre-and post-procedural TIMI flow grades.
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The total number of stenotic and treated vessels, reference vessel diameters, stenosis percentages, balloon diameters and lengths, stent diameters and maximal inflation pressures and the ejection fractions were also similar among the groups. The percentage of left circumflex coronary artery (LCx) intervention was higher in the cTn-I(+) patients compared with the cTn-I(−) patients (44.4% versus 23.3%, respectively, P = 0.03). The lesion and stent lengths and the total number and total duration of balloon dilatations were also significantly higher in the cTn-I(+) group compared with the cTn-I(−) group (P = 0.02, P = 0.04, P = 0.001 and P = 0.001, respectively). Tirofiban was administered during PCI to five patients, all of whom were cTn-I(+).
PREDICTIVE FACTORS OF CARDIAC TROPONIN-I ELEVATION
All significant univariate predictors from Tables 1 and 2 (haemoglobin level, LCx interventions, length of the target lesions and implanted stents, total number and overall duration of balloon dilatations) were analysed by multiple stepwise logistic regression analysis using the backward method. After the fifth step, only the basal haemoglobin level (OR 0.6, 95% confidence interval [CI] 0.44, 0.85, P = 0.004) and total number of balloon dilatations (OR 2.3, 95% CI 1.32, 4.17, P = 0.003) appeared to have significant effects on cTn-I positivity.
From the ROC curve analysis, sensitivity and 1 -specificity for a haemoglobin level of 12.85 g/dl was 91% and 44%, respectively Fig. 1 ). Fifteen patients (55.6%) of the cTn-I(+) group and six patients (8.2%) of the cTn-I(−) group had a haemoglobin level less than or equal to the cut-off value of 12.85 g/dl determined from the ROC analysis. The distribution of haemoglobin levels between the two groups is shown in Fig. 2 . The Spearman correlation test showed significant correlation between basal haemoglobin levels and cTn-I elevation (≤ 12.85 g/dl, r = 0.6, P < 0.001). Haemoglobin and cTn-I levels were related inversely. Repetitive balloon dilatation increased the risk of post-procedural cTn-I elevation by 2.3 times.
CLINICAL OUTCOMES
Coronary dissection occurred in three patients and three patients suffered from major side-branch total occlusion. Two of the patients with coronary dissection and the one patient with major side-branch total occlusion were in the cTn-I(+) group. There was no significant difference between the groups with respect to procedural complications. At the end of all interventional procedures, TIMI grade 3 flow was achieved in 96 of the 100 patients, so the overall procedural success rate was 96% (Table 2) . No residual stenosis occurred during PTCA or stenting procedures. Because of the relatively low incidence of cardiac end-points, the combined major adverse cardiovascular events were subjected to survival analysis. Nine (33.3%) of the cTn-I(+) patients and 12 (16.4%) of the cTn-I(−) patients suffered from at least one cardiovascular end-point during follow-up. Three (11.1%) of the cTn-I(+) patients had an 
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AMI after the first 24-h period and the overall number increased to five (18.5%) in the first month. However, none of the cTn-I(−) patients had an AMI during followup. The patient who suffered a cardiac death 9 months after the intervention was in the cTn-I(−) group. In 12 ± 1.2 months of follow-up, a recurrent intervention was required for four (14.8%) cTn-I(+) patients and 11 (15.1%) cTn-I(−) patients. There was a significant relationship between in-hospital outcome and cTn-I positivity (OR 2.7, 95% CI 1.39, 5.37, P = 0.04) and the relationship remained significant at 1 month (OR 2.5, 95% CI 1.37, 4.82, P = 0.02).
At 1 year, the relationship was not significant (Table 3 ).
Discussion
Asymptomatic myocardial injury is frequent after conventional PCIs, with a reported incidence of 10 -30% in different studies. 3 -5,11 However, there is debate regarding the threshold of cardiac enzymes that reflect significant myocardial injury and the association of this level with cardiovascular end-points. It has been reported in a recent meta-analysis comprising 23 230 patients that any post-procedural CK-MB level above normal was associated with increased mortality risk. 7 However, the results of the studies investigating the relationship between cTn elevation after successful PCI and cardiovascular end-points are contradictory. A number of studies have reported no association between elevated post-procedural cTn-I levels and cardiovascular end-points, 12 -14 whilst several studies have shown a significant relationship. 15 -19 A number of factors may be responsible for these conflicting data. The data could be obtained by chance in some of the studies that included patients with elevated baseline troponin values, and many different troponin kits with different threshold values were used by the A number of studies have investigated the association between clinical and demographic properties of patients and post-PCI cTn elevations. In these studies, significant relationships were found between the patients' age, gender, left ventricular ejection fraction, unstable angina and diffuse atherosclerotic disease with cTn-I elevation. 12, 14, 19 In comparison, the results from this study found only that lower basal haemoglobin values were negatively related to cTn-I elevation, and this relationship remained significant after the multivariate analysis.
It is well known that anaemia is associated with increased mortality in AMI and heart failure patients. 20 In a recent study by Lee et al., 21 anaemia was identified as an independent predictor of mortality after PCI. McKechnie et al. 22 also reported that anaemic men and women had worse in-hospital outcomes after PCI compared with their respective non-anaemic cohort. Coronary ischaemia originates from an imbalance between the coronary blood flow and myocardial oxygen demand. It is possible that the patients with lower baseline haemoglobin values, even when the levels do not meet the anaemia criteria, are more prone to myocardial ischaemia during repetitive balloon dilatations, distal embolization with atherothrombotic material and prolonged coronary spasm, which can take place during PCI. The results of our study could have been obtained by chance since there was a limited study population; however, the persistence of this finding after multivariate analysis suggests that this subject deserves to be investigated in larger, randomized studies.
A number of trials have investigated the effect of angiographic morphological features on post-procedural cardiac enzyme elevation and troponin positivity. Different studies have identified multivessel disease, complex plaque morphology, high plaque burden, stenosis percentage and saphenous vein graft intervention as predictors of postprocedural troponin elevation. 12, 23, 24 In the present study, only the lesion length and LCx vessel intervention were associated with post-procedural cTn-I elevation in the univariate analysis; however, this association lost its significance in the multivariate analysis.
It has been reported that the type of intervention also affects the elevation of cTn after PCI. 25 This elevation is highest when atherectomy and stent implantation are applied concomitantly and lowest after PTCA-only procedures. However, more invasive interventions may have been applied for more complex lesions, which could have resulted in higher post-procedural levels of cardiac enzymes and troponin. We observed postprocedural cTn-I positivity in 11 of 49 patients (22%) with a stent-only procedure, 14 of 43 patients (33%) with combined PTCA and intracoronary stenting, and two of eight patients (25%) with PTCA only. The difference failed to reach statistical significance. The very small size of the PTCA-only group may be responsible for this unexpected result. Invasive interventions such as atherectomy and laser angioplasty were not applied, so their effect on post-procedural cTn-I elevation could not be investigated, which is a limitation of this study.
There are few data regarding the relationship between post-PCI troponin elevation and procedural parameters. Saadeddin et al. 26 investigated the postprocedural cTn-I positivity in 85 low-risk patients. They reported that the total duration of balloon inflation showed a Significance of troponin-I release after coronary angioplasty significant relationship with post-procedural cTn-I levels. A study by Bertinchant et al. 12 reported a significant association between a single balloon inflation of greater than 90 s and cTn-I positivity after multivariate analysis. In the present study, implanted stent lengths and the total number and overall duration of balloon dilatations were significantly associated with postprocedural cTn-I positivity. When these significant parameters were evaluated by multivariate analysis, surprisingly, only the total number of balloon dilatations remained significant.
The effect of mechanical complications during a PCI, such as occlusive coronary dissection, side-branch occlusion, the noreflow phenomenon, intracoronary thrombus and distal embolization on the elevation of cardiac enzymes and troponins is well known. 14, 19 The incidence of these complications was very low in the present study, with three coronary dissections and three instances of major side-branch total occlusion. However, only three of six patients with mechanical complications had post-procedural cTn-I positivity. It seems that mechanical complications are only partially responsible for post-procedural cardiac enzyme elevation. In a study by Angelini et al., 27 the embolic particle was identified within a distal protection filter in 75.6% of 36 patients with stable or unstable angina pectoris, after conventional PCI. The histopathological examination of this material revealed 69 -79% thrombus and 21 -31% plaque material. In most cases, this event is observed without any clear mechanical complication, which suggests the presence of microembolization.
In order to avoid myocardial injury during PCI, trials of intracoronary nitrate, β-blockers, glycoprotein IIb/IIIa inhibitors and adenosine have been carried out. 28 -31 However, only glycoprotein IIb/IIIa inhibitors have changed the standard treatment modalities. In the present study, no intravenous medication was applied during PCI, except for glycoprotein IIb/IIIa administration, which was limited to five patients, all of whom were in the cTn-I(+) group. However, it is hard to interpret this as indicating an association between drug infusion and cTn-I positivity, as glycoprotein IIb/IIIa infusion was restricted to patients with angiographically high-risk lesions and the procedures with mechanical complications.
In conclusion, when analysing the data obtained from the present study and other studies that have evaluated the effect of procedural parameters, it is necessary to consider the possibility that distal embolization of thrombotic and atherosclerotic material is the primary event that gives rise to increased cardiac enzyme and troponins in procedures without mechanical complications. The relationship between the total number of balloon dilatations and postprocedural cTn-I positivity probably reflects the effect of repetitive trauma on the atherosclerotic plaque, which leads to an increased amount of embolized atherosclerotic material. However, it seems wise to accept any post-PCI troponin elevation as a warning sign of short-term cardiovascular events, especially for in-hospital AMI.
